Back to Search
Start Over
Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System.
- Source :
-
Molecular pharmacology [Mol Pharmacol] 2019 Dec; Vol. 96 (6), pp. 809-818. Date of Electronic Publication: 2019 Apr 30. - Publication Year :
- 2019
-
Abstract
- Atypical chemokine receptor 3 (ACKR3), previously known as C-X-C chemokine receptor type 7 (CXCR7), has emerged as a key player in several biologic processes, particularly during development. Its CXCL11 and CXCL12 scavenging activity and atypical signaling properties, together with a new array of other nonchemokine ligands, have established ACKR3 as a main regulator of physiologic processes at steady state and during inflammation. Here, we present a comprehensive review of ACKR3 expression in mammalian tissues in search of a possible connection with the receptor function. Besides the reported roles of ACKR3 during development, we discuss the potential contribution of ACKR3 to the function of the immune system, focusing on the myeloid lineage.<br /> (Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.)
Details
- Language :
- English
- ISSN :
- 1521-0111
- Volume :
- 96
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Molecular pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 31040166
- Full Text :
- https://doi.org/10.1124/mol.118.115329